Open research questions in Cancer, Stress, Anesthesia, and Immune Response
103 unresolved questions extracted from the limitations and future-work sections of 277 Cancer, Stress, Anesthesia, and Immune Response papers in our library. Each links back to the study that raised it.
What the literature leaves open
The need for a comprehensive integration of mechanistic, pharmacologic, and translational evidence. The lack of emphasis on CSC-associated effects and autophagy disruption in prior reviews. The need to critically evaluate exposure-response limitations and biomarker-guided strategies.
Repurposing Antipsychotic Agents in Oncology: Mechanistic Rationale, Emerging Evidence, and Therapeutic Potential · 2026 · DOIinvestigate the mechanisms by which propofol influences Wnt–Frizzled-related transcriptional responses, - examine the effects of propofol on other types of cancer cells, - conduct clinical trials to determine the therapeutic potential of propofol in pancreatic cancer treatment, - explore the potential of propofol as a chemotherapeutic agent
Propofol-Induced Metabolic, Apoptotic, and Wnt–Frizzled-Related Transcript Changes in MIA PaCa-2 Cells: In Vitro and Bioinformatic Analyses · 2026 · DOIThe relationship between propofol and Wnt-Frizzled-related transcriptional responses in pancreatic cancer cells is not well understood. The effects of propofol on MIA PaCa-2 cells have not been fully characterized. The clinical evidence for the influence of anesthetic and analgesic exposures on tumor-cell behavior during the perioperative period is unsettled.
Propofol-Induced Metabolic, Apoptotic, and Wnt–Frizzled-Related Transcript Changes in MIA PaCa-2 Cells: In Vitro and Bioinformatic Analyses · 2026 · DOIThere is a lack of direct trials showing that aligning anesthesia, analgesia, and immunonutrition improves recovery through an immune mechanism. Current evidence on the effects of anesthetic and analgesic strategies on immune activity is limited and heterogeneous. There is a need for further research on the relationship between anesthesia, analgesia, and immunonutrition in perioperative immune homeostasis.
Anesthesia, analgesia, and immunonutrition in perioperative immune homeostasis: a focused mini review · 2026 · DOICurrent evidence does not establish clinical anticancer efficacy for CGRP blockade or nociceptor ablation, - Translational development is needed to proceed through pharmacodynamic window studies, tumor-specific biomarker enrichment, and combination trials, - Long-term safety assessment is required, - Oncology dose finding and tumor-response endpoints need to be established
The CGRP-nociceptor axis in cancer: tumor-specific programs of immune evasion, stromal remodeling, and tumor growth · 2026 · DOITranslational development should proceed through pharmacodynamic window studies, tumor-specific biomarker enrichment, and combination trials, - Studies should measure structural innervation together with neuronal activation, local CGRP release, receptor engagement, and the proposed cellular output, - Research on the role of CGRP in inflammation-associated colorectal tumorigenesis is needed
The CGRP-nociceptor axis in cancer: tumor-specific programs of immune evasion, stromal remodeling, and tumor growth · 2026 · DOIThe complexity of corticosteroid use in oncology, with multiple factors contributing to their negative effects - The need to balance the benefits and risks of corticosteroid use in cancer care - The challenge of developing safer, more effective therapeutic strategies to replace or complement corticosteroids
Exploring safer alternatives to CSs, - Investigating dietary interventions, - Examining the effects of renin-angiotensin system blockers and vitamin D optimization
Translational investigation, - Development of rational, pathway-directed combination strategies
Repurposing Antipsychotic Agents in Oncology: Mechanistic Rationale, Emerging Evidence, and Therapeutic Potential · 2026 · DOIDirect trials of integrated anesthesia-analgesia-immunonutrition pathways are now needed to connect these mechanistic pathways with recovery outcomes
Anesthesia, analgesia, and immunonutrition in perioperative immune homeostasis: a focused mini review · 2026 · DOIWe also outline key challenges to clinical translation, such as the spatiotemporal heterogeneity of neuroimmune regulation, the narrow therapeutic window of neuropharmacological agents, and the lack of standardized biomarkers.
The neuroimmune axis in breast cancer: from mechanistic insights to clinical applications · 2026 · DOIGiven that all components of PTM regimens are clinically effective and safe, further clinical studies are warranted.
Non-steroidal anti-inflammatory drugs (NSAIDs) regimens enhance synergistic selective anticancer efficacy of chemotherapeutic agents on cultured cells · 2025 · DOIConcomitant medications are increasingly recognized for their immunomodulatory properties, yet interactions within complex cancer regimens are underexplored.
Investigating the influence of baseline medications on immune checkpoint inhibitor treatment outcomes for cancer patients 3706 · 2025 · DOINeurotransmitter (NT) signaling, known to be immunosuppressive in various disease models, is underexplored in the tumor microenvironment (TME).
Neurotransmitter modulation of anti-tumor responses: new avenues for enhancing immunotherapy 2602 · 2025 · DOIAbstract Description Early onset colorectal cancer (CRC) incidence rates have significantly increased over the past two decades, but the underlying mechanisms are poorly understood.
Chronic stress is a recognized risk factor for tumor progression, but its specific role in TNBC remains unclear.
While perineural invasion (PNI) is associated with poor prognosis in CRC, the impact of nerve density and diameter on tumor behavior remains unclear.
Increased nerve density adversely affects outcome in colorectal cancer and denervation suppresses tumor growth · 2025 · DOIHowever, challenges such as the non-specific nature of SNS blockade and the complexity of TME interactions necessitate further research into ARs subtypes, tumor-specific metabolic vulnerabilities, and predictive biomarkers.
Sympathetic nervous system in tumor progression and metabolic regulation: mechanisms and clinical potential · 2025 · DOIBACKGROUND: The therapeutic impact of beta-blockers (BB), beta-adrenergic receptor antagonists, on prostate cancer remains controversial.
Beta-blockers prolong response to androgen deprivation therapy in prostate cancer through modulation of the neuro-immuno-oncology axis · 2025 · DOIBACKGROUND Perioperative blood transfusion is common in gastric cancer surgery, yet its impact on postoperative inflammation, stress response, and long-term prognosis remains incompletely understood.
Influence of blood transfusion on postoperative inflammation, stress markers, and prognosis in patients with gastric cancer · 2025 · DOIEmerging evidence underscores the critical, yet frequently underrecognized, role of the nervous system in the development and progression of gastric cancer (GC), primarily mediated through complex neuro-tumoral interactions and modulation of immune responses.
However, whether tumor-derived exosomes (TDEs) are influenced by chronic stress and participate in chronic stress-mediated distant metastasis remains unclear.
Chronic Stress‐Induced and Tumor Derived SP1 + Exosomes Polarizing IL‐1β + Neutrophils to Increase Lung Metastasis of Breast Cancer · 2024 · DOIWhile preclinical investigations focusing on anesthetics' impact on the behavior of cancer cells are quite convincing, limited clinical trials studying the consequences on survival and recurrences remain inconclusive.
However, the mechanisms underlying its anti-tumor effects have not been fully elucidated.
Anti-Proliferative Effects of Lidocaine as an Autophagy Inducer in Bladder Cancer via Intravesical Instillation: In Vitro and Xenograft Mouse Model Experiments · 2024 · DOIGeneral anaesthetics are often used on patients undergoing painful procedures during ALL treatments but their effects on ALL malignancy remain unknown.
General anaesthetics reduce acute lymphoblastic leukaemia malignancies in vitro and in vivo via CXCR4 and osteopontin mediated mechanisms · 2024 · DOI
Most-cited papers in Cancer, Stress, Anesthesia, and Immune Response
- Inflammation and cancer: back to Virchow? · The Lancet · 2001 · 6,331 citations
- Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer · New England Journal of Medicine · 2005 · 1,760 citations
- Cancer-cell-derived GABA promotes β-catenin-mediated tumour growth and immunosuppression · Nature Cell Biology · 2022 · 278 citations
- Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer model · Acta Pharmacologica Sinica · 2012 · 188 citations
- Neuronal substance P drives metastasis through an extracellular RNA–TLR7 axis · Nature · 2024 · 169 citations
- First Week Movement Activities for Elementary/Middle School Teachers: Getting to Know You. · Teaching elementary physical education · 2005 · 160 citations
- Progressive plasticity during colorectal cancer metastasis · Nature · 2024 · 149 citations
- Nerve-to-cancer transfer of mitochondria during cancer metastasis · Nature · 2025 · 147 citations
- Nociceptive neurons promote gastric tumour progression via a CGRP–RAMP1 axis · Nature · 2025 · 137 citations
- Characterization of single neurons reprogrammed by pancreatic cancer · Nature · 2025 · 131 citations
Most recent work
- Sensory neurons drive immune exclusion by stimulating a dense extracellular matrix in the breast cancer tumor microenvironment · Cell · 2026
- Cancer neuroscience: signaling pathways and new therapeutic strategies for cancer · Signal Transduction and Targeted Therapy · 2026
- The neuroimmune axis in breast cancer: from mechanistic insights to clinical applications · BMC Medicine · 2026
- Targeting sensory nerves in the tumor microenvironment: a new vulnerability in cancer therapy · Cell Communication and Signaling · 2026
- The neural niche in cancer: mechanistic insights into tumor–neuron–immune crosstalk and therapeutic opportunities · Frontiers in Cell and Developmental Biology · 2026
- Advances in the Pathophysiology and Management of Cancer Pain: A Scoping Review · Cancers · 2026
- Unraveling the nexus in the neuro-neoplastic progression of colorectal cancer: Potential role of β2-adrenergic receptor (β2-AR) · Journal of Advanced Research · 2026
- Immunomodulatory Effects of Lidocaine: Mechanisms of Actions and Therapeutic Applications · Pharmaceuticals · 2026
- The Neuro–Bone Axis in Metastatic Progression: Innervation, Neuro-Immune–Osteoclast Crosstalk, and Therapeutic Opportunities · Biology · 2026
- The neuro-vascular-immune triad: the interactive network in the tumor microenvironment · Cell Communication and Signaling · 2026
Find a gap in your own Cancer, Stress, Anesthesia, and Immune Response sub-topic
This page shows what the Cancer, Stress, Anesthesia, and Immune Response literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 4.5M-paper local library and writes the gaps from its rows.
Open the Research Gap Finder →